GlassScriptPhysician profile
Danish Ali
NPI 1609214253
$12,005.34
in general payments reported to CMS, 2019-2025
35 companies · $2,150 in 2025
The $2,150 reported for 2025 was more than what 87% of Pain Medicine (Physical Medicine & Rehabilitation) providers received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,614 · 2020: $1,398 · 2021: $559 · 2022: $1,292 · 2023: $1,262 · 2024: $2,731 · 2025: $2,150.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,597 · Travel and Lodging: $530 · Gift: $15.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,597.37 |
| Travel and Lodging | $529.80 |
| Gift | $15.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,693.10 | 2021-2025 | Intellis Adaptivestim, Inceptiv, Synchromedii |
| Boston Scientific Corporation | $2,615.17 | 2019-2025 | General - Pain Management, Wavewriter Alpha Prime 16, Infinion 16 |
| Abbott Laboratories | $2,127.27 | 2019-2025 | Proclaim, Eterna, Prodigy |
| Nevro Corp. | $1,268.80 | 2019-2024 | Senza |
| Genesys Orthopedics Systems, L.L.C. | $649.80 | 2024 | Sacroiliac Joint Fusion System |
| Globus Medical, INC. | $429.35 | 2024-2025 | Senza, Excelsius3d Imaging System |
| Abbvie INC. | $358.37 | 2022-2024 | Botox, Qulipta |
| Biotronik Nro, INC. | $331.70 | 2024-2025 | Prospera |
| Medtronic USA, INC. | $229.85 | 2019-2020 | |
| Stryker Corporation | $169.72 | 2023 | Mako |
| Biodelivery Sciences International, INC. | $154.86 | 2019 | |
| Aimmune Therapeutics, INC. | $124.91 | 2025 | Zenpep |
| Horizon Therapeutics Plc | $105.51 | 2019-2021 | |
| Relievant Medsystems, INC. | $72.36 | 2021 | |
| Allergan, INC. | $69.69 | 2021 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biosense Webster, INC. | $67.90 | 2024 | Carto 3 |
| Collegium Pharmaceutical, INC. | $67.88 | 2025 | Belbuca, Xtampza |
| Painteq LLC | $66.63 | 2022-2023 | Painteq |
| Amgen INC. | $55.16 | 2021-2022 | |
| Fidia Pharma USA INC. | $46.58 | 2022-2023 | Triluron, Hymovis |
| Averitas Pharma INC. | $35.54 | 2024 | Qutenza |
| Bioventus LLC | $31.82 | 2023-2024 | Durolane, Gelsyn-3 |
| Kowa Pharmaceuticals America, INC. | $27.76 | 2022-2023 | Seglentis |
| Pfizer INC. | $26.60 | 2024 | |
| Vertos Medical, INC. | $22.74 | 2022 | |
| Impel Pharmaceuticals LLC | $22.48 | 2025 | Trudhesa |
| Ipsen Biopharmaceuticals, INC | $21.54 | 2022 | |
| Spr Therapeutics, INC | $17.79 | 2023 | Sprint Pns System |
| Curonix LLC | $17.42 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Astrazeneca Pharmaceuticals LP | $15.47 | 2019 | |
| Daiichi Sankyo INC. | $14.67 | 2019 | |
| Ibsa Pharma INC. | $13.50 | 2021 | |
| Arbor Pharmaceuticals, INC. | $12.82 | 2020 | |
| Lilly USA, LLC | $12.67 | 2019 | |
| Epimed International, INC | $7.91 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danish Ali listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.